Nephrostomy Devices Market (By Product: Nephrostomy Catheters, Guidewires, Sheath Dilators, Drainage Tubes, Others; By End Use: Emergency Clinics, Hospitals, Ambulatory Surgical Centers) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format: PDF | Status: Published | Pages : 190

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Nephrostomy Devices
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Nephrostomy Devices Market By Product
1.2.2.1. Global Nephrostomy Devices Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.2.2. Global Nephrostomy Devices Market Revenue Share By Product in 2017
1.2.2.3. Nephrostomy Catheters
1.2.2.4. Guidewires
1.2.2.5. Sheath Dilators
1.2.2.6. Drainage Tubes
1.2.2.7. Others
1.2.3. Nephrostomy Devices Market By End Use
1.2.3.1. Global Nephrostomy Devices Market Revenue and Growth Rate Comparison By End Use (2015-2026)
1.2.3.2. Global Nephrostomy Devices Market Revenue Share By End Use in 2017
1.2.3.3. Emergency Clinics
1.2.3.4. Hospitals
1.2.3.5. Ambulatory Surgical Centers
1.2.4. Nephrostomy Devices Market by Geography
1.2.4.1. Global Nephrostomy Devices Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.4.2. North America Nephrostomy Devices Market Revenue and Growth Rate (2015-2026)
1.2.4.3. Europe Nephrostomy Devices Market Revenue and Growth Rate (2015-2026)
1.2.4.4. Asia-Pacific Nephrostomy Devices Market Revenue and Growth Rate (2015-2026)
1.2.4.5. Latin America Nephrostomy Devices Market Revenue and Growth Rate (2015-2026)
1.2.4.6. Middle East and Africa (MEA) Nephrostomy Devices Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Nephrostomy Devices Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Nephrostomy Devices Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Nephrostomy Devices Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Nephrostomy Devices Major Manufacturers in 2017

CHAPTER 4. NEPHROSTOMY DEVICES MARKET BY PRODUCT

4.1. Global Nephrostomy Devices Revenue By Product
4.2. Nephrostomy Catheters
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Guidewires
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Sheath Dilators
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Drainage Tubes
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Others
4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. NEPHROSTOMY DEVICES MARKET BY END USE

5.1. Global Nephrostomy Devices Revenue By End Use
5.2. Emergency Clinics
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Hospitals
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Ambulatory Surgical Centers
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. NORTH AMERICA NEPHROSTOMY DEVICES MARKET BY COUNTRY

6.1. North America Nephrostomy Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. North America Nephrostomy Devices Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. U.S.
6.3.1. U.S. Nephrostomy Devices Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
6.4. Canada
6.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
6.5. Mexico
6.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)

CHAPTER 7. EUROPE NEPHROSTOMY DEVICES MARKET BY COUNTRY

7.1. Europe Nephrostomy Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Europe Nephrostomy Devices Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. UK
7.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
7.4. Germany
7.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
7.5. France
7.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
7.6. Spain
7.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
7.7. Rest of Europe
7.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)

CHAPTER 8. ASIA-PACIFIC NEPHROSTOMY DEVICES MARKET BY COUNTRY

8.1. Asia-Pacific Nephrostomy Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Asia-Pacific Nephrostomy Devices Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. China
8.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
8.4. Japan
8.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
8.5. India
8.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
8.6. Australia
8.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
8.7. South Korea
8.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
8.8. Rest of Asia-Pacific
8.8.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.8.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)

CHAPTER 9. LATIN AMERICA NEPHROSTOMY DEVICES MARKET BY COUNTRY

9.1. Latin America Nephrostomy Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Latin America Nephrostomy Devices Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Brazil
9.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
9.4. Argentina
9.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
9.5. Rest of Latin America
9.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)

CHAPTER 10. MIDDLE EAST NEPHROSTOMY DEVICES MARKET BY COUNTRY

10.1. Middle East Nephrostomy Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Middle East Nephrostomy Devices Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Saudi Arabia
10.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
10.4. UAE
10.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
10.5. Rest of Middle East
10.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)

CHAPTER 11. AFRICA NEPHROSTOMY DEVICES MARKET BY COUNTRY

11.1. Africa Nephrostomy Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Africa Nephrostomy Devices Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. South Africa
11.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
11.4. Egypt
11.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
11.5. Rest of Africa
11.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)

CHAPTER 12. COMPANY PROFILE

12.1. Cardinal Health
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Product Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. Teleflex, Inc.
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Product Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. Becton, Dickinson and Company
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Product Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. Argon Medical
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Product Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. Boston Scientific Corp.
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Product Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. Cook Medical
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Product Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. Coloplast Group
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Product Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. B. Braun Melsungen AG
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Product Portfolio
12.8.5. Key Developments
12.8.6. Strategies
12.9. Olympus Corp.
12.9.1. Company Snapshot
12.9.2. Overview
12.9.3. Financial Overview
12.9.4. Product Portfolio
12.9.5. Key Developments
12.9.6. Strategies
12.10. Uresil LLC
12.10.1. Company Snapshot
12.10.2. Overview
12.10.3. Financial Overview
12.10.4. Product Portfolio
12.10.5. Key Developments
12.10.6. Strategies
12.11. Others
12.11.1. Company Snapshot
12.11.2. Overview
12.11.3. Financial Overview
12.11.4. Product Portfolio
12.11.5. Key Developments
12.11.6. Strategies

CHAPTER 13. RESEARCH APPROACH

13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope


Cart Summary